The increase in migraine frequency-with shift towards chronicity-promotes an enhancement of the central hypersensitivity which has been linked with fibromyalgia and myositis (FM). Migraine patients with FM have been known to have higher burden of headaches across studies, but this is the first population-based study to evaluate disability and morbidity in migraine patients with concurrent FM. We performed a retrospective cross-sectional analysis of migraine hospitalizations using the nationwide database to determine cost, hospital stay, disability, and discharge disposition. This analysis was performed in migraine patients with and without FM using ICD-9-CM codes. We performed weighted analyses using chi-square and t test. Among year 2014 hospitalizations, we identified FM patients and regression analysis was performed to evaluate whether migraine or other headache disorders were predictors of FM hospitalization. Between years 2003 and 2014, of the total 446,446 migraine hospitalizations, 22,735(5.09%) patients had concurrent FM. Migraine patients with FM had higher prevalence of loss of function (8.4% vs. 6.5%, p<0.0001) and transfer to rehabilitation facilities (5.5% vs. 4.5%, p<0.0001) compared to those without FM. Migraine patients with FM also had higher hospitalization stay and cost. Through regression analysis, we found that migraine (aOR, 3.03; p<0.0001), cluster headache (aOR, 1.71; p=0.0124), and tension headache (aOR, 1.87; p<0.0001) were highly associated with FM hospitalization. FM was associated with significant increase in disability, morbidity, hospitalization stay, and cost in patients admitted with migraine. On the basis of this study finding, it would be reasonable to screen migraine patients with depression, anxiety, or other psychiatric disorders for symptoms of FM to mitigate the burden.
Introduction
Migraines are a type of headache disorder, affecting 14% of the population, associated with debilitating pain, recurrent episodes, nausea, and sensitivity to light and sound [1] . FM is chronic musculoskeletal disorders characterized by widespread pain, tenderness, and fatigue, as well as cognitive dysfunction. The reported prevalence of fibromyalgia is 2.0 to 5.7% [1] . While the cause of FM remains unknown, it is hypothesized that central sensitization causes the persistence of musculoskeletal pain. Central sensitization involves a noxious stimulus that leads to permanent damage to nociceptive pathways [2] . Pain persistence in migraine may be due to central sensitization, indicating a possible cause of comorbidity between fibromyalgia and migraine [2] . In a study by Centonze et al., it is suggested that fibromyalgia and episodic migraine may be a continuum of the same disease [3] . FM has been shown to be associated with more severe headaches and poorer quality of life in migraine patients [4] [5] [6] . In this retrospective cross-sectional study, we hypothesized that concurrent FM among migraineurs is associated with higher disability and morbidity.
Primary objective of this study was to investigate if FM predicts disability and morbidity in the subset of large inpatient sample with 446,446 migraine hospitalizations. Secondary objective was to study whether migraine or other headache disorders predict FM hospitalizations.
Methods
Data was obtained from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project (HCUP) NIS files between January 2003 and December 2014. The NIS is the largest publicly available all-payer inpatient care database in the USA and contains discharge-level data provided by states that participate in the HCUP (including a total of 46 in 2011). This administrative dataset contains data on approximately 8 million hospitalizations in 1000 hospitals that were chosen to approximate a 20% stratified sample of all US community hospitals, representing more than 95% of the national population. Criteria used for stratified sampling of hospitals into the NIS include hospital ownership, patient volume, teaching status, urban or rural location, and geographic region. Discharge weights are provided for each patient discharge record, which allow extrapolation to obtain national estimates. Each hospitalization is treated as an individual entry in the database and is coded with one principal diagnosis, up to 24 secondary diagnoses, and 15 procedural diagnoses associated with that stay. Detailed information on NIS is available at http://www.hcup-us. ahrq.gov/db/nation/nis/nisdde.jsp
Study Population
We used the 9th revision of the International Classification of Diseases, clinical modification code (ICD-9-CM) to identify adult patients admitted to hospital with a primary diagnosis of migraine (ICD-9-CM code 346). Similarly, patients with fibromyalgia and myositis were identified as secondary diagnosis associated with migraine using ICD-9-CM code 729.1. Age <18 years and admissions with missing data for age, gender, and race were excluded. The sample size was based on the available data. We used ICD-9-CM codes to identify patients with Cluster Headache 339.0 and Tension Type Headache 339.1 or 307.81.
Patient and Hospital Characteristics
Patient characteristics of interest were age, gender, race, insurance status, and concomitant diagnoses as defined above. Race was defined by white (referent), African American, Hispanic, Asian or Pacific Islander, and Native American. Insurance status was defined by Medicare (referent), Medicaid, Private Insurance, and Other/Self-pay/No charge. We defined the severity of comorbid conditions using Deyo's modification of the Charlson's Comorbidity Index ( Supplementary Table 1 ). Facilities were considered to be teaching hospitals if they have an American Medical Association-approved residency program, are a member of the Council of Teaching Hospitals, or have a full-time equivalent interns and residents to patient's ratio of ≥0.25. HCUP NIS contains data on total charges for each hospital in the databases, which represents the amount that hospitals billed for services.
Outcomes
We tried to find out disability, morbidity, length of stay (LoS), and cost of hospitalization associated with FM among migraine hospitalizations (years 2003-2014). The comparison of disability/loss of function was investigated by All Patient Refined Diagnosis Related Groups (APR-DRGs) severity between patients with FM and patients without FM. APR-DRGs were assigned using software developed by 3M Health Information Systems, where score 1 indicates minor loss of function, 2 moderate, 3 major, and 4 extreme loss of function. Morbidity was defined as length of stay ≥7 days (≥95 percentile or +1.5 SD) and discharge other than home (short-term hospital, skilled nursing facility, intermediate care facility).
Our secondary outcome of interest was to evaluate whether headache disorders worsen FM which leads to FM-related hospitalization among January 2014-December 2014 US hospitalizations. The reason to choose only year 2014 data for secondary outcome was the large number of US hospitalizations (more than 20 million) each year to evaluate patients with and without FM and headache disorders.
Statistical Analysis
All statistical analyses were performed using the weighted survey methods in SAS (version 9.4). Weighted values of patient-level observations were generated to produce a nationally representative estimate of the entire US population of hospitalized patients. A p value of <0.05 was considered significant. Univariate analysis of differences between categorical variables was tested using the chi-square test and analysis of differences between continuous variables (length of stay and cost of hospitalization) was tested using paired Student's t test. Mixed-effects survey logistic regression models with weighted analysis were used for the categorical dependent variables, including migraine and outcomes of interest, in order to estimate odds ratio (OR) and 95% confidence interval for the association between headache disorders (migraine, cluster headache, tension headache) and migraine in year 2014 cohort.
We included demographics (age, gender, race), patient-level hospitalization variables (admission day, primary payer, admission type, Median Household Income Category), hospital-level variables (hospital region, teaching versus non-teaching hospital, hospital bed size), comorbidities like hypertension, diabetes mellitus, hypercholesterolemia, obesity, smoking status, drug abuse, alcohol abuse, depression, generalized anxiety disorders, other psychiatric disorders, and Charlson's Comorbidity Index (CCI).
For each model, C-index (a measure of goodness of fit for binary outcomes in a logistic regression model) was calculated. All statistical tests used were two-sided, and p<0.05 was deemed statistically significant. No statistical power calculation was conducted prior to the study.
Results

Disease Hospitalizations
We found a total of 596,231 hospitalizations (446,446: weightedafter removing missing data for age, gender and ethnicity) due to migraine from year 2003 to 2014 after excluding patients with age <18 years and admissions with missing data for age, gender, and ethnicity ( Fig. 1 ). Out of 446,446 migraine hospitalizations, 22,735 (5.09%) had FM and 423,711 (94.91%) had no FM.
Prevalence Trends
We analyzed trends of FM in migraine hospitalizations. As shown in Fig. 2 , trends of FM were increasing from 2003 to 2014. (FM, 3.02% in 2003 to 6.91% in 2014; P-Trend <0.0001).
Demographics, Patient and Hospital Characteristics, and Comorbidities
FM was more in common in 35-65 years of age group. Migraine hospitalizations with FM were more likely to be in female (96.27% vs. 79.68%, p<0.0001), white (82.02% vs. 73.23%, p< 0.0001), had private insurance (49.47% vs. 54.76%, p<0.0001), and elective admissions (12.45% vs. 9.71%, p<0.0001) than those with absent FM. Comorbidities like depression, generalized anxiety disorder, other psychiatric disorders and neurological disorders, arthritis, diabetes, hypertension, obesity, drug abuse, and current or past tobacco consumption were higher among FM patients than those without FM. Overall, hospitalizations with FM also have a high percentage of CCI (Deyo's Charlson's Comorbidity) Index ( Table 1 ). 
The Outcomes
Regression Model Derivation
Among year 2014 of total 28,212,820 hospitalizations, we had considered 26,614,100 patients after excluding age <18 years and admissions with missing data for age, gender, and race. Out of which 411,835 (1.55%) patients had FM. Among this population, we looked for concurrent headache disorders and other comorbidities which could predict the FM hospitalizations. In the multivariate regression analysis, after adjusting for basic demographic with patient and hospital-level variables, comorbidities, concurrent conditions, and CCI, patients with migraine (adjusted OR, 3.03; 95% CI, 2.95-3.12; p<0.0001), cluster headache (adjusted OR, 1.71; 95% CI, 1.12-2.59; p=0.0124), and tension headache (adjusted OR, 1.87; 95% CI, 1.21-2.89; p<0.0001) were at higher risk of having hospitalizations due to FM than non-headache disorders ( Table 3) . Accuracy of the Model c-statistic was 0.799 which is used to validate the accuracy of the regressions. Adjusted model has c-index >0.7, which indicates a good model.
Discussion
The major finding from our study is high prevalence of FM in patients with migraine hospitalizations. Despite of different origin of pain, both FM and migraine are comorbidities due to central sensitization phenomenon [7] . Response to somatic hyperalgesia was enhanced by concurrent fibromyalgia and migraine than one condition alone. Higher migraine frequency and/or chronicity provokes hyperalgesia and fibromyalgia pain, which is reversed by effective migraine prophylaxis according to Giamberardino et al. [8] . Several studies have reported high prevalence of fibromyalgia in migraineurs [9] [10] [11] [12] [13] . A retrospective cohort study, fibromyalgia in migraine, by Whealy et al., found that patients with comorbid FM and migraine reported higher average headache intensity and severity than their age and sex-matched controls, who had migraine alone [4] . This reflects the findings of other studies, that in patients with FM, headaches are more likely to be rated as incapacitating, as compared to patients without FM [5] . While the Marcus et al. study found that there is not a significant difference in pain and cognitive distress between FM patients The model is adjusted for basic demographic with patient-level variables, comorbidities, CCI, concurrent conditions, and hospital-level variables such as hospital region, teaching status, and bed size UL upper limit, LL lower limit with migraine and FM patients without migraine, 76% of the FM patients seeking treatment suffered from chronic headache, indicating that headaches should be screened for in FM patients [14] . FM is associated with low quality of life in patients with migraine [9, 10] . A study by Beyazal et al. found that in migraine patients, FM comorbidity showed a significant impact on the patients' quality of life. Those with FM had more frequent migraines, significantly higher mean widespread pain scores, and lower quality of life scores [6] . Our study corroborates previous findings by showing high prevalence of major/severe loss of function in migraine patient with FM as compared to those without FM (p<0.0001). We also found that migraineurs with FM had higher rates of discharge dispositions other than home, higher length of stay, and higher cost of hospitalizations than migraineurs without FM.
Similar to previous studies we also found a significantly higher prevalence of migraine and FM in females as compared to males [12, 15, 16] . Total 96.27% patients were females for migraine with FM and 79.68% were females for migraine without FM. In 2006, Aloisi et al. reported the different expression of pain between sexes is due to interaction between sex hormones, brain functions, and processing of pain [17] . We found increased prevalence of depression, generalized anxiety disorder, and other psychiatric disorders in migraine patient compared to those without FM similar to prior studies [9, 10, 12, 13] . Decreased pain habituation is common in migraine and FM and may lead to central sensitization and myofascial pain persistence in the presence of other favorable situations, such as depression, sleep disturbances, and anxiety [13] . Mongini et al. [18] have reported that the presence of anxiety alone or combined with depression significantly increase the level of muscle tenderness in the head and more in the neck might facilitate into chronic headache forms such as migraine. Similarly, anxiety may also increase FM and diffuse myofascial pain comorbidity in headache patients who present with increased pericranial muscle tenderness. Whealy et al. concluded that concurrent migraine and fibromyalgia patients have severe depressive symptoms, higher headache intensity, and severe headache-related disability; thus, migraineur should be evaluated for fibromyalgia especially with depressive symptoms, high headache intensity, or high headacherelated disability [4] . According to Costantini et al., visceral pain due to comorbid irritable bowel syndrome, primary dysmenorrhea, endometriosis, and colon diverticulosis triggers fibromyalgia pain and hyperalgesia in female patients probably due to enhancing the level of central sensitization which decreases significantly after treatment. In such patients, an assessment and treatment of visceral pain comorbidities should be a part of management strategy [19] .
Screening for FM in patients with migraine hospitalizations may be helpful in identifying this under-recognized comorbidity. Treatment of FM with cognitive behavioral therapy, exercise, and drug therapy may help improve outcomes in migraine patients as well because of high impact of FM on disability and quality of life in these patients. On basis of central sensitization phenomenon, Yilmaz et al. had evaluated the efficacy of greater occipital nerve blockage in patients with concurrent migraine and fibromyalgia and found it reduces pain severity, headache frequency, duration, and increases quality of life [20] .
A major strength of the study was that findings were nationally representative for the USA. NIS data is a largest inpatient database, and our study has good statistical power. APR-DRG coding system used in this study to assess the severity of illness is external validated. It is a reliable method with accurate and consistent results and is widely used by hospitals, consumers, payers, and regulators [21, 22] . However, there are limitations to the study. Since this is an inpatient population-based study, there might be underreporting of concurrent prevalence as all migraine and FM patients are not hospitalized and managed as outpatients. ICD-9-CM code recognizes fibromyalgia and myositis as a combined code so burden of individual diseases cannot be established. Data from clinical registries are obtained retrospectively by chart abstractions based on the discharge diagnosis codes, billing codes, etc. and hence susceptible to coding errors. In such cross-sectional study, it is difficult to identify temporal relationship between FM and headache disorder.
Conclusion
The conclusion derived from the study data is the understanding of the significant association of FM with migraine and other headache disorders and its role in increasing burden of disability, morbidity, LOS, and cost of hospitalization among migraineurs. The evaluation of FM comorbidity in different types of chronic headache subtype patients may increase the knowledge about chronicization mechanism and central sensitization phenomenon. Our findings suggest the importance of screening for FM in migraine and other headache disorders due to significant impact of FM on quality of life. This will also help in creating the optimal individual treatment plan. On the basis of this study finding, it would also be reasonable to screen migraine patient with depression, anxiety, or other psychiatric disorders for symptoms of FM.
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